A previous study found that downregulation of RCC1 could sensitize immunotherapy by upregulating PD-L1 via the p27kip1/CDK4 pathway in non-small cell lung cancer, and the expression of RCC1 was inversely related to the amount of immune cell infiltration [18]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.